Evidence map›Paper›PMID 39735398›Full record

ArticleJournal of biomedical optics2024

Investigating ocular biomarkers and differential diagnosis of Alzheimer's disease and vascular cognitive impairment based on multimodal imaging.

Zi Jin, Xuhui Chen, Chunxia Jiang, Ximeng Feng, Kun Shang, Jinying Li, Qiushi Ren, Chuanqing Zhou

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zi JinEye Hospital, Wenzhou Medical University, National Engineering Research Center of Ophthalmology and Optometry, Wenzhou, China.ORCID 0000-0001-6443-7058
Xuhui ChenPeking University Shenzhen Hospital, Department of Neurology, Shenzhen, China.
Chunxia JiangPeking University Shenzhen Hospital, Department of Ophthalmology, Shenzhen, China.
Ximeng FengPeking University Shenzhen Graduate School, Institute of Biomedical Engineering, Shenzhen, China.
Kun ShangShanghai University of Medicine and Health Sciences, College of Medical Instruments, Shanghai, China.
Jinying LiPeking University Shenzhen Hospital, Department of Ophthalmology, Shenzhen, China.
Qiushi RenPeking University Shenzhen Graduate School, Institute of Biomedical Engineering, Shenzhen, China.
Chuanqing ZhouShanghai University of Medicine and Health Sciences, College of Medical Instruments, Shanghai, China.ORCID 0000-0002-9030-4993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: The eye can be used as a potential monitoring window for screening, diagnosis, and monitoring of neurological diseases. Alzheimer's disease (AD) and vascular cognitive impairment (VCI) are common causes of cognitive impairment and may share many similarities in ocular signs. Multimodal ophthalmic imaging is a technology to quantify pupillary light reaction, retinal reflectance spectrum, and hemodynamics. This provides multidimensional ocular metrics from a non-invasive approach to ocular biomarkers and differential diagnosis of AD and VCI. Aim: We aim to investigate the changing pattern of ocular metrics in patients with AD and VCI using multimodal ophthalmic imaging. Approach: Patients with subjective cognitive complaints in the memory clinic were subdivided into AD, VCI, and cognitively healthy individuals using neuropsychological and neuroimaging examinations, including positron emission tomography. All subjects underwent a medical history review, blood pressure measurement, medical optometry, intraocular pressure measurement, and custom-built multimodal ophthalmic imaging. Multidimensional parameters were analyzed by one-way analysis of variance and Results: This study included 19 patients with AD, 24 patients with VCI, and 37 cognitively healthy age- and sex-matched subjects. Both AD and VCI patients showed abnormal pupillary light reactions, including decreased resting pupil diameter, pupil constriction amplitude, and maximum constriction velocity. Compared with the control group, the AD group presented increased retinal reflectance at 548 nm, whereas the VCI group presented an increased resistivity index and decreased blowout score in retinal hemodynamics. Conclusions: We demonstrate that pupillary light reaction-related neurodegeneration is the common pathological change in both AD and VCI. In addition, AD is characterized by alterations in retinal spectral signatures, whereas VCI is characterized by alterations in retinal hemodynamics. These findings suggest that multimodal ophthalmic imaging may have the potential to be used as a screening tool for detecting AD and VCI.

Indexed as

Alzheimer DiseaseBiomarkersCognitive DysfunctionMultimodal ImagingAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMaleMiddle AgedPositron-Emission TomographyPupilRetinaBiomarkersAlzheimer’s diseasemultimodal ophthalmic imagingpupillary light reactionretinal hemodynamicsretinal reflectance spectrumvascular cognitive impairment

Identifiers

PMID39735398
PMCPMC11672116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.